Fatma Allouche
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Fatma Allouche has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Fakher Chabchoub
Université de Sfax
4 shared publicationsAsma Agrebi
Hétérocycles, Corps Gras et Polymères, Faculté des Sciences de Sfax, Université de Sfax
2 shared publications- Laurent El Kaïm
Laboratoire de Synthèse Organique (LSO) CNRS Ecole Polytechnique ENSTA Institut Polytechnique de Paris Palaiseau Cedex France
2 shared publications Abderrahman Bouraoui
Faculté de Pharmacie, Université de Monastir
1 shared publicationAhlem Rahali
Laboratoire de Chimie Médicinale et Environnementale, Institut Supérieur de Biotechnologie, Route de la Soukra km 4, 3038 Sfax, Tunisia
1 shared publicationAmine Karoui
Hétérocycles, Corps Gras et Polymères, Faculté des Sciences de Sfax, Université de Sfax
1 shared publication
Latest Publications
- Open Access
- 20 June 2025
- Published by MathDoc/Centre Mersenne in Comptes Rendus. Chimie
- Vol. 28 (G1) , 561-571
Synthesis of C5-arylated pyrazoles from a pyrazole-4-carboxylate by a palladium-catalyzed C5–H bond activation/C4-decarboxylation sequence
In the context of palladium-catalyzed C–H bond arylation, it has been well-established that pyrazoles, with both C4 and C5 available positions, typically result in the formation of mixtures of C4-, C5-arylated, and also C4, C5-diarylated products. In this study, the reactivity of ethyl 1-methylpyrazole-4-carboxylate in palladium-catalyzed C–H arylation was investigated. The objective was to determine the effectiveness of the presence of an ester substituent at the C4 position of the pyrazole as a blocking group in controlling the regioselectivity of such C–H bond arylations. It was observed that the presence of such an ester substituent acted as a convenient blocking group, thereby enabling the control of regioselectivity in the arylation process at the C5 position of the pyrazole. The reaction exhibits a high degree of tolerance to a wide variety of aryl bromides, including a diverse array of functional groups at the para , meta , and ortho positions of the aryl bromides. Heteroarylation is also possible. In the course of these couplings, no decarboxylation of the pyrazole unit was observed, and the reaction requires only 2 mol% of an air-stable phosphine-free palladium catalyst and KOAc as an inexpensive base. Furthermore, the removal of the pyrazole ester substituent was found to be easy, which demonstrates the potential of such an ester substituent as a removable blocking group.
- 20 June 2025
- Published by MathDoc/Centre Mersenne in Comptes Rendus. Chimie
- Vol. 28 (G1) , 561-571
Open AccessSynthesis of C5-arylated pyrazoles from a pyrazole-4-carboxylate by a palladium-catalyzed C5–H bond activation/C4-decarboxylation sequence
In the context of palladium-catalyzed C–H bond arylation, it has been well-established that pyrazoles, with both C4 and C5 available positions, typically result in the formation of mixtures of C4-, C5-arylated, and also C4, C5-diarylated products. In this study, the reactivity of ethyl 1-methylpyrazole-4-carboxylate in palladium-catalyzed C–H arylation was investigated. The objective was to determine the effectiveness of the presence of an ester substituent at the C4 position of the pyrazole as a blocking group in controlling the regioselectivity of such C–H bond arylations. It was observed that the presence of such an ester substituent acted as a convenient blocking group, thereby enabling the control of regioselectivity in the arylation process at the C5 position of the pyrazole. The reaction exhibits a high degree of tolerance to a wide variety of aryl bromides, including a diverse array of functional groups at the para , meta , and ortho positions of the aryl bromides. Heteroarylation is also possible. In the course of these couplings, no decarboxylation of the pyrazole unit was observed, and the reaction requires only 2 mol% of an air-stable phosphine-free palladium catalyst and KOAc as an inexpensive base. Furthermore, the removal of the pyrazole ester substituent was found to be easy, which demonstrates the potential of such an ester substituent as a removable blocking group.
- Open Access
- 1 January 2022
- Published by Walter de Gruyter GmbH in Heterocyclic Communications
- Vol. 28 (1) , 11-17
Study of the reactivity of aminocyanopyrazoles and evaluation of the mitochondrial reductive function of some products
This research investigated the general high-throughput synthetic protocol for the accelerated synthesis of functionalized trifluoromethylpyrazolopyrimidines 3 and N -(5-cyano-3-methyl-1-phenyl-1 H -pyrazol-4-yl) benzamide 4 from aminocyanopyrazole 1 precursors. The action of chlorosulfonyl isocyanate (CSI) with aminopyrazolo[3,4- d ]pyrimidines 2 was found to produce triazolopyrimidinones 5 . The MTT test that quantifies mitochondrial reductive function demonstrated that in both cell lines tested (PE/CA-PJ41 and HePG2 cells), the benzamide compounds 4 are moderately toxic with PE/CA-PJ41 cells and more sensitive than HePG2 cells.
- 1 January 2022
- Published by Walter de Gruyter GmbH in Heterocyclic Communications
- Vol. 28 (1) , 11-17
Open AccessStudy of the reactivity of aminocyanopyrazoles and evaluation of the mitochondrial reductive function of some products
This research investigated the general high-throughput synthetic protocol for the accelerated synthesis of functionalized trifluoromethylpyrazolopyrimidines 3 and N -(5-cyano-3-methyl-1-phenyl-1 H -pyrazol-4-yl) benzamide 4 from aminocyanopyrazole 1 precursors. The action of chlorosulfonyl isocyanate (CSI) with aminopyrazolo[3,4- d ]pyrimidines 2 was found to produce triazolopyrimidinones 5 . The MTT test that quantifies mitochondrial reductive function demonstrated that in both cell lines tested (PE/CA-PJ41 and HePG2 cells), the benzamide compounds 4 are moderately toxic with PE/CA-PJ41 cells and more sensitive than HePG2 cells.
- 5 February 2015
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 24 (6) , 2732-2741
Synthesis, antimicrobial and antioxidant activities of imidazotriazoles and new multicomponent reaction toward 5-amino-1-phenyl[1,2,4]triazole derivatives
- 5 February 2015
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 24 (6) , 2732-2741
Synthesis, antimicrobial and antioxidant activities of imidazotriazoles and new multicomponent reaction toward 5-amino-1-phenyl[1,2,4]triazole derivatives
- Open Access
- 4 September 2013
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 23 (3) , 1591-1598
Synthesis and pharmacological evaluation of pyrazolopyrimidopyrimidine derivatives: anti-inflammatory agents with gastroprotective effect in rats
We report the synthesis of new anti-inflammatory 1,7-dihydropyrazolo[3′,4′:4,5]pyrimido[1,6-a]pyrimidine 5 from aminocyanopyrazole. All compounds were characterized by physical, chemical and spectral studies. Preliminary pharmacological evaluation of the resulting products showed that compounds 5a, b, f (50–100 mg/kg, i.p) are active anti-inflammatory agents in carrageenan-induced rat paw oedema assay, and their effects are comparable to that of acetylsalicylic–lysine (300 mg/kg, i.p.), used as a reference drug. The nature of substituent (Y, R3) had a pronounced effect on the anti-inflammatory activity. Studies of structure–activity relationships have led to selection of compound ethyl-3,5-dimethyl-7-imino-N 1-phenyl-1,7-dihydropyrazolo[3′,4′:4,5]pyrimido[1,6-a]pyrimidine-6-carboxylate, 5f which exhibited the most potent anti-inflammatory activity. In addition, the compounds 5a, b, f showed a significant gastroprotective effect against HCl/EtOH-induced gastric ulcer.
- 4 September 2013
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 23 (3) , 1591-1598
Open AccessSynthesis and pharmacological evaluation of pyrazolopyrimidopyrimidine derivatives: anti-inflammatory agents with gastroprotective effect in rats
We report the synthesis of new anti-inflammatory 1,7-dihydropyrazolo[3′,4′:4,5]pyrimido[1,6-a]pyrimidine 5 from aminocyanopyrazole. All compounds were characterized by physical, chemical and spectral studies. Preliminary pharmacological evaluation of the resulting products showed that compounds 5a, b, f (50–100 mg/kg, i.p) are active anti-inflammatory agents in carrageenan-induced rat paw oedema assay, and their effects are comparable to that of acetylsalicylic–lysine (300 mg/kg, i.p.), used as a reference drug. The nature of substituent (Y, R3) had a pronounced effect on the anti-inflammatory activity. Studies of structure–activity relationships have led to selection of compound ethyl-3,5-dimethyl-7-imino-N 1-phenyl-1,7-dihydropyrazolo[3′,4′:4,5]pyrimido[1,6-a]pyrimidine-6-carboxylate, 5f which exhibited the most potent anti-inflammatory activity. In addition, the compounds 5a, b, f showed a significant gastroprotective effect against HCl/EtOH-induced gastric ulcer.
- 1 August 2013
- Published by Wiley in European Journal of Organic Chemistry
- Vol. 2013 (26) , 5805-5808
Cyclization Cascade of Hydrazono Ugi Adducts towards Pyrazoles
Acidic hydrolysis of Ugi adducts formed from α‐hydrazonocarboxylic acids and aminoacetaldehyde dimethyl acetal leads to the fragmentation of aminoacetaldehyde residues with final formation of pyrazoles. An aldol‐type reaction of the hydrazone is proposed as the key step of the cascade.
- 1 August 2013
- Published by Wiley in European Journal of Organic Chemistry
- Vol. 2013 (26) , 5805-5808
Cyclization Cascade of Hydrazono Ugi Adducts towards Pyrazoles
Acidic hydrolysis of Ugi adducts formed from α‐hydrazonocarboxylic acids and aminoacetaldehyde dimethyl acetal leads to the fragmentation of aminoacetaldehyde residues with final formation of pyrazoles. An aldol‐type reaction of the hydrazone is proposed as the key step of the cascade.
- Open Access
- 27 September 2012
- Published by Taylor & Francis in Journal of Enzyme Inhibition and Medicinal Chemistry
- Vol. 28 (2) , 343-349
Synthesis of aminocyanopyrazoles via a multi-component reaction and anti-carbonic anhydrase inhibitory activity of their sulfamide derivatives against cytosolic and transmembrane isoforms
A convenient protocol for the multicomponent reaction (MCRs) between malononitrile with an orthoester and hydrazine derivatives, under acid catalyst is described. A series of aminocyanopyrazoles 4 was prepared, isolated and characterized. These pyrazoles reacted with sodium nitrite followed by secondary amine reagent and with formic acid to lead pyrazolotriazines 6 and pyrazolopyrimidinones 7. Some of the aminopyrazoles were converted to the corresponding sulfamides by reaction with sulfamoyl chloride. The aminopyrazoles incorporating phenyl and tosyl moieties were tested as inhibitors of four carbonic anhydrase (CA, EC 4.2.1.1) isoforms, the human (h) hCA I, II, IX and XII. Many of them showed low micromolar or submicromolar inhibition of these enzymes. The corresponding sulfamides were low nanomolar CA inhibitors.
- 27 September 2012
- Published by Taylor & Francis in Journal of Enzyme Inhibition and Medicinal Chemistry
- Vol. 28 (2) , 343-349
Open AccessSynthesis of aminocyanopyrazoles via a multi-component reaction and anti-carbonic anhydrase inhibitory activity of their sulfamide derivatives against cytosolic and transmembrane isoforms
A convenient protocol for the multicomponent reaction (MCRs) between malononitrile with an orthoester and hydrazine derivatives, under acid catalyst is described. A series of aminocyanopyrazoles 4 was prepared, isolated and characterized. These pyrazoles reacted with sodium nitrite followed by secondary amine reagent and with formic acid to lead pyrazolotriazines 6 and pyrazolopyrimidinones 7. Some of the aminopyrazoles were converted to the corresponding sulfamides by reaction with sulfamoyl chloride. The aminopyrazoles incorporating phenyl and tosyl moieties were tested as inhibitors of four carbonic anhydrase (CA, EC 4.2.1.1) isoforms, the human (h) hCA I, II, IX and XII. Many of them showed low micromolar or submicromolar inhibition of these enzymes. The corresponding sulfamides were low nanomolar CA inhibitors.